Dana Pe’er's lab endeavors to understand the organization, function, and evolution of molecular networks, particularly how variation in DNA sequence alters regulatory networks and leads to the vivid phenotypic diversity of life. Her team develops computational methods that integrate diverse high-throughput data to provide a holistic, systems-level view of molecular networks. She is particularly interested in exploring how systems biology can be used to personalize care for people with cancer. By developing models that can predict how individual tumors will respond to certain drugs and drug combinations, her goal is to develop ways to determine the best drug regime for each patient. Her interest is not only in understanding which molecular components go wrong in cancer cells, but also in using this information to improve cancer therapeutics.
Dr. Pe’er is the recipient of the 2014 Overton Prize, and has been recognized with the Burroughs Wellcome Fund Career Award, an NIH Directors New Innovator Award, an NSF CAREER Award, and a Stand Up To Cancer Innovative Research Grant. She was also named a Packard Fellow in Science and Engineering.